Published in Blood on February 13, 2003
A role for IL-27 in limiting T regulatory cell populations. J Immunol (2011) 1.17
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol (2005) 1.80
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses (2009) 1.66
Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol (2005) 1.50
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology (2002) 1.40
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med (2009) 1.34
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27
Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun (2004) 1.12
Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain (2003) 1.10
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem (2002) 1.09
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology (2003) 1.00
Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther (2012) 1.00
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol (2002) 0.98
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. J Biol Chem (2011) 0.97
Human immunodeficiency virus type 1 latency model for high-throughput screening. Antimicrob Agents Chemother (2005) 0.94
The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys. J Neuroimmunol (2006) 0.94
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation (2012) 0.91
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol (2011) 0.91
Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibody. J Immunol (2009) 0.91
HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. J Immunol (2009) 0.90
Cannabinoids decrease the th17 inflammatory autoimmune phenotype. J Neuroimmune Pharmacol (2013) 0.89
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma. Blood (2010) 0.89
Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood (2004) 0.88
Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J Immunol (2006) 0.88
Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. J Clin Invest (2002) 0.86
OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207. Eur J Immunol (2007) 0.83
A HIV-2-based self-inactivating vector for enhanced gene transduction. J Biotechnol (2006) 0.83
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 0.83
A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice. Blood (2013) 0.83
A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. J Neuroimmunol (2004) 0.82
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication. Retrovirology (2013) 0.82
In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol (2009) 0.81
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Res Ther (2011) 0.80
Involvement of phosphodiesterases in autoimmune diseases. J Neuroimmunol (2010) 0.80
Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve. Eur J Immunol (2008) 0.80
The influence of follicular migration on T-cell differentiation. Immunology (2004) 0.79
The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev (2009) 0.79
Post-transcriptionally regulated expression system in human xenogeneic transplantation models. Mol Ther (2011) 0.78
'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides. PLoS One (2011) 0.78
Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues. Eur J Immunol (2007) 0.77
HIV type-1 latency: targeted induction of proviral reservoirs. Antivir Chem Chemother (2009) 0.77
Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). Int Immunol (2008) 0.77
Choice and use of appropriate packaging cell types. Methods Mol Biol (2003) 0.77
Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol (2006) 0.77
Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, beta-synuclein. J Neuroimmunol (2009) 0.76
The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control. Oncogene (2002) 0.76
Neuroprotection induced by mucosal tolerance is epitope-dependent: conflicting effects in different strains. J Neuroimmunol (2006) 0.76
An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action. J Biol Chem (2013) 0.75
New strategies for immune-mediated anti-viral drug and vaccine development. Curr Pharm Des (2006) 0.75
Pillars Article: The Rapid Isolation of Clonable Antigen-specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis. Eur J Immunol. 1981.11: 195-199. J Immunol (2017) 0.75
Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency. Autoimmunity (2010) 0.75
Isolation of multilineage progenitors from mouse brain. In Vitro Cell Dev Biol Anim (2013) 0.75